WO2014116015A3 - 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법 - Google Patents

자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법 Download PDF

Info

Publication number
WO2014116015A3
WO2014116015A3 PCT/KR2014/000609 KR2014000609W WO2014116015A3 WO 2014116015 A3 WO2014116015 A3 WO 2014116015A3 KR 2014000609 W KR2014000609 W KR 2014000609W WO 2014116015 A3 WO2014116015 A3 WO 2014116015A3
Authority
WO
WIPO (PCT)
Prior art keywords
bamboo salt
disease
purple bamboo
composition
alzheimer
Prior art date
Application number
PCT/KR2014/000609
Other languages
English (en)
French (fr)
Other versions
WO2014116015A2 (ko
Inventor
함경식
조정용
키티퐁
박선영
주금예
Original Assignee
목포대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 목포대학교산학협력단 filed Critical 목포대학교산학협력단
Priority to US14/443,259 priority Critical patent/US10124031B2/en
Publication of WO2014116015A2 publication Critical patent/WO2014116015A2/ko
Publication of WO2014116015A3 publication Critical patent/WO2014116015A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 800℃ 내지 1200℃에서 열처리된 열처리 소금을 유효성분으로 하고 약학적 또는 식품학적으로 허용 가능한 기타 성분을 포함하는 알츠하이머병 예방용 기능성 조성물을 제공한다. 상기 조성물은 알츠하이머병의 인체 내 유발 경로를 효과적으로 차단함으로써 알츠하이머병의 발병을 예방할 수 있다. [대표도] 도3
PCT/KR2014/000609 2013-01-24 2014-01-22 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법 WO2014116015A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/443,259 US10124031B2 (en) 2013-01-24 2014-01-22 Composition for preventing Alzheimer's disease, containing purple bamboo salt, and method for preparing purple bamboo salt

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130007827A KR20140095202A (ko) 2013-01-24 2013-01-24 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법
KR10-2013-0007827 2013-01-24

Publications (2)

Publication Number Publication Date
WO2014116015A2 WO2014116015A2 (ko) 2014-07-31
WO2014116015A3 true WO2014116015A3 (ko) 2014-10-23

Family

ID=51228165

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2014/000609 WO2014116015A2 (ko) 2013-01-24 2014-01-22 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법

Country Status (3)

Country Link
US (1) US10124031B2 (ko)
KR (1) KR20140095202A (ko)
WO (1) WO2014116015A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3243476B1 (en) 2014-03-24 2019-11-06 Auris Health, Inc. Systems and devices for catheter driving instinctiveness
CN104587271A (zh) * 2015-02-11 2015-05-06 郭如英 适宜先天智力缺陷儿童服用的益智药剂及制备
CN110200258A (zh) * 2019-07-17 2019-09-06 成都食为天科技有限公司 一种高叶绿素竹盐及其制备方法
CN113142539A (zh) * 2020-01-23 2021-07-23 杭州尤美特科技有限公司 一种竹盐及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120132064A (ko) * 2011-05-27 2012-12-05 목포대학교산학협력단 자죽염을 유효성분으로 하는 위염 및 위궤양 예방제로서의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009281748A1 (en) * 2008-08-15 2010-02-18 Board Of Regents, The University Of Texas System 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
KR20120134264A (ko) * 2011-06-02 2012-12-12 목포대학교산학협력단 자죽염을 포함하는 당뇨 예방 또는 개선을 위한 식품 첨가물 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120132064A (ko) * 2011-05-27 2012-12-05 목포대학교산학협력단 자죽염을 유효성분으로 하는 위염 및 위궤양 예방제로서의 용도

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AIGUO XUAN ET AL.: "Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammtion in beta-amyloid rat model of Alzheimer's disease.", JOURNAL OF NEUROINFLAMMATION., vol. 9, no. 202, 17 August 2012 (2012-08-17), pages 1 - 11 *

Also Published As

Publication number Publication date
KR20140095202A (ko) 2014-08-01
US10124031B2 (en) 2018-11-13
US20150297664A1 (en) 2015-10-22
WO2014116015A2 (ko) 2014-07-31

Similar Documents

Publication Publication Date Title
HK1250714A1 (zh) 雜芳基衍生物或其藥學上可接受的鹽、其製備方法以及包含其作為活性成分的用於預防或治療pi3激酶相關疾病的藥物組合物
WO2016064082A3 (ko) 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
EP4374873A3 (en) Methods for treating or preventing opthalmological conditions
WO2015165413A8 (zh) 一种新型的稳定型抗体药物耦联物及其制备方法和用途
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
EP3176163A4 (en) Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EP3138834A4 (en) Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
WO2015173701A3 (en) Pharmaceutical compositions comprising danirixin for treating infectious diseases
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
WO2014116015A3 (ko) 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
WO2015048188A3 (en) Modified fibroblast growth factors for the treatment of ocular disorders
EP3311817A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF EYES DISEASES WITH IMATINIB AS AN ACTIVE SUBSTANCE
EP2886112A4 (en) COMPOSITION CONTAINING AS ACTIVE INGREDIENT OF S-ALLYL-L-CYSTEINE FOR PREVENTING OR TREATING OCULAR DISEASES, AND PHARMACEUTICAL FORMULATION COMPRISING THE SAME
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
WO2016138270A3 (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
EP3260121A4 (en) Composition for preventing, alleviating or treating metabolic diseases, containing amodiaquine as active ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14743572

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14443259

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 14743572

Country of ref document: EP

Kind code of ref document: A2